by Scott Miller | Oct 24, 2022
Around the world, 2.5 billion people need assistive products and services. Yet nearly one billion of them are denied access, particularly in low- and middle-income countries, where access can be as low as 3 percent of the need for these life-changing products. For...
by Scott Miller | Oct 12, 2022
As part of a growing portfolio of biomedical HIV prevention options, long-acting injectable cabotegravir (CAB-LA) was approved by the US FDA in December 2021. Evidence from two clinical trials, HPTN 083 and HPTN 084, which enrolled nearly 8,000 participants across 13...
by Scott Miller | Sep 19, 2022
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI. Lakshmi Balachandran Senior Director, Digital Health London, UK Start date: August 2013 Sameen Babur Senior Technical Advisor, Health Informatics Washington, D.C., USA...
by Scott Miller | Aug 25, 2022
Four things you should know about darunavir Introduction A critical second-line HIV treatment called darunavir/ritonavir (DRV/r) is rolling out across Nigeria and Zambia – some of the earliest adopters of many countries that can now access an affordable supply of...
by Scott Miller | Aug 22, 2022
Hepatitis C (HCV) is an infectious, bloodborne virus that causes liver inflammation and can lead to liver failure and cancer. It is a silent killer, as patients do not exhibit any symptoms. Every 30 seconds, a person dies from a hepatitis-related illness; elimination...
by Scott Miller | Aug 11, 2022
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI. Please tell us a bit about your background and what brought you to CHAI For as long as I can remember, I have always been interested in tackling pressing societal...
